Elite Pharmaceuticals Inc (ELTP)

[no2koolaid]

I have thought about Merck, Mallinckrodt, Novartis and Abbvie. I even considered Mylan because of the generics and the potential to enter a new therapeutic area that, down the line with Elite, could offer a line of ADF generics. But I sought to do what critical thinking requires...not consider the possibilities but, rather, the probabilities. And, those really center around the factors that are driving pharma M&A today. With that, I believe there is much awareness by big pharma about Elite, as with any others developing ADFs. Big pharma wants the smaller guys to develop it, bring it to if not through approval, then look at a potential partnership or, if the numbers argue, acquire. The acquisition scenario becomes even more compelling when you consider that the only way to compete in the future may well be through ADFs.